In this study, the negative expression of DLL4 in LFS and cancer cells was not restricted to only tissue culture cell lines but it was also evident in tumor tissues from invasive ductal carcinoma, renal carcinoma, prostate adenocarcinoma, small cell carcinoma, hepatocellular carcinoma, and neuroblastoma. This evidence concerns the gene DLL4 and neuroblastoma.